ariessence is intended to be used as a viscous, leave-on solution designed for topical application to the face. It is intended to be used following non-medical cosmetic procedures, performed by licensed healthcare professionals to enhance comfort and maintain skin hydration. This study is designed to be a multi-center, post-market cosmetic evaluation of ariessence applied to the full face after an ablative laser procedure to evaluate improvements in procedure tolerability and improvements in the appearance of the skin, compared to an emollient control.
Age range
40 Years – 70 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Clinical Measures
Timeframe: Baseline (Day 0) through Day 84 (End of Study).
Patient-Reported Outcomes
Timeframe: Baseline through day 84
Photography
Timeframe: Baseline through Day 84
Investigator Objective Tolerability Assessment
Timeframe: Baseline through Day 84
Erythema grading (0-4 scale)
Timeframe: Baseline through Day 84 (End of Study)
Clinician's Global Aesthetic Improvement Scale (CGAIS).
Timeframe: Baseline through Day 84 (End of STudy)